08/18/2026
EDUCATIONAL TUESDAY!!! THE NEW GLP-1 BRIDGE PROGRAM IS GOING STRONG.....DON'T GET LEFT BEHIND........
Started in July 2026, some people with Medicare will be eligible for Medicare coverage of certain weight-loss medications through the new Medicare GLP‑1 Bridge Program.
Background
Under federal law, Medicare Part D plans cannot cover medications prescribed for weight loss, among several other “excluded” categories of drugs and indications. Medications that are FDA-approved for both weight loss and other indications may only be covered by Part D plans for non-weight loss indications.
GLP-1 drugs, which include medications used to treat type 2 diabetes, obesity, cardiovascular disease, and other conditions, have greatly increased in popularity in recent years due to their demonstrated effectiveness. But the federal exclusion limits Medicare coverage of these drugs.
STOP BY AND LET US SEE IF YOU QUALIFY!!!